San
Francisco, 12 December 2018, Global DNA testing market is anticipated to reach USD 10.04 billion by
2022, according to a new study by Grand View Research Inc. Rise in developments
in the field of genome sequencing and personalized DNA level diagnostic
applications, a considerable growth in the number of patented research
initiatives by the government and government funded projects are factors
expected to drive demand during the forecast period.
Introduction of novel technologies for genome profiling
are expected to boost progress of this industry over the forecast period.
Furthermore, increasing incidences of chronic oncology and infectious diseases
that depend on DNA prototyping for treatment and diagnosis using personalized
medicine are anticipated to significantly raise demand for DNA
diagnostics/testing based research thereby propelling industrial growth in the
coming years. Increasing demand for prenatal testing and in-vitro fertilization that subsequently leads to
rise in demand for DNA diagnostics/testing is also attributive towards expected
progress in this market.
Access Full Research
Report On DNA testing market Analysis:
www.grandviewresearch.com/industry-analysis/dna-testing-market
www.grandviewresearch.com/industry-analysis/dna-testing-market
Further key findings from the study suggest:
·
PCR based diagnosis accounted
for the largest share of the market revenue in 2014 as a result of higher
preference rate coupled with higher availability of products and reagent kits
of this segment.
·
Next generation sequencing
application for DNA testing is estimated to witness significant progress with a
double digit CAGR of over 16% amongst the other technology segments due to
presence of significant advantages offered by this technique of DNA identification
and testing.
·
Infectious disease diagnostics
accounted for the largest market share in 2014 due to higher incidence rate of
various infectious disorders which subsequently raises the demand for in-vitro nucleic acid based diagnostic tests for
diagnosis and monitoring of disease progression.
·
There are diverse applications
of DNA testing market out of which oncology diagnostics and histopathology is
estimated to register lucrative growth over the forecast period. Factors
attributing for considerable growth potential in this segment include
identification of cancer causing genes & associated research, and
facilitation in mutation detection
·
North America dominated the
market in 2014, with revenue estimated at over USD 2,600 million. Presence of
sophisticated healthcare infrastructure, rising incidence of genetic
abnormalities, favorable government initiatives with respect to genetic
diagnosis and its application in in-vitro fertilization
are major factors driving growth of this region.
·
Asia Pacific is anticipated to
witness lucrative growth as a result of developments in health care
infrastructure in this region coupled with presence of significant number of
target population that is suffering with chronic as well as acute disorders.
Government initiatives taken up herein are also attributive to influence sector
growth to a great extent.
·
Key participants of DNA testing
industry include Abbott Laboratories, Agilent Technologies Inc., Illumina Inc.,
Beckman Coulter Inc., Bio-Rad Laboratories, Thermo Fisher Scientific, Applied
Biosystems Group, Cepheid Inc., Transgenomic Inc., Siemens Healthcare, Roche
Diagnostics, Qiagen, Illumina, GE Healthcare, Alere Inc, Affymetrix Inc.,
Hologic, Dako, and 454 Life Sciences.
Browse More Reports Of This Category By
Grand View Research At: www.grandviewresearch.com/industry/biotechnology
Grand View Research has segmented DNA
testing market on the basis of technology, application, and region:
Global DNA
Diagnostics/Testing Technology Outlook (Revenue, USD Million, 2012 - 2022)
·
Microarrays based diagnostics
·
PCR based diagnostics
·
In-situ hybridization
diagnostics
·
NGS DNA diagnosis
Global DNA Diagnostics/Testing
Application Outlook (Revenue, USD Million, 2012 - 2022)
·
Prenatal DNA Carrier Screening
·
Preimplantation Diagnosis
·
Newborn Genetic Screening
·
Infectious Disease Diagnostics
o
HBV Diagnostic
o
HCV Diagnostic
o
HIV Diagnostic
o
TB Diagnostic
o
CT/NG Diagnostic
o
HPV Diagnostic
o
MRSA Diagnostic
o
Others
·
Oncology Diagnostics &
Histopathology
·
Identity Diagnostics &
Forensics
·
Pharmacogenomics Diagnostic
Testing
·
Drug Metabolism & P450
effects
·
Others
DNA Diagnostics/Testing
Regional Outlook (Revenue, USD Million, 2012 - 2022)
·
North America
o
U.S.
o
Canada
·
Europe
o
Germany
o
UK
·
Asia Pacific
o
Japan
o
China
·
Latin America
o
Brazil
o
Mexico
·
MEA
o
South Africa
Access Full Press Release of this Report:
www.grandviewresearch.com/press-release/global-dna-testing-market
www.grandviewresearch.com/press-release/global-dna-testing-market
About Grand View Research
Grand View Research, Inc. is a U.S. based market research and
consulting company, registered in the State of California and headquartered in
San Francisco. The company provides syndicated research reports, customized
research reports, and consulting services. To help clients make informed
business decisions, we offer market intelligence studies ensuring relevant and
fact-based research across a range of industries, from technology to chemicals,
materials and healthcare.
For more information: www.grandviewresearch.com/
